Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Current Assets (2021 - 2025)

Roivant Sciences (ROIV) has disclosed Current Assets for 5 consecutive years, with $4.7 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Assets rose 609.48% year-over-year to $4.7 billion, compared with a TTM value of $4.7 billion through Dec 2025, up 609.48%, and an annual FY2025 reading of $5.0 billion, down 25.73% over the prior year.
  • Current Assets was $4.7 billion for Q4 2025 at Roivant Sciences, up from $4.5 billion in the prior quarter.
  • Across five years, Current Assets topped out at $6.7 billion in Q1 2024 and bottomed at $635.7 million in Q4 2023.
  • Average Current Assets over 5 years is $3.1 billion, with a median of $2.1 billion recorded in 2021.
  • The sharpest move saw Current Assets tumbled 61.39% in 2023, then skyrocketed 609.48% in 2025.
  • Year by year, Current Assets stood at $2.1 billion in 2021, then fell by 19.99% to $1.6 billion in 2022, then crashed by 61.39% to $635.7 million in 2023, then grew by 3.33% to $656.8 million in 2024, then surged by 609.48% to $4.7 billion in 2025.
  • Business Quant data shows Current Assets for ROIV at $4.7 billion in Q4 2025, $4.5 billion in Q3 2025, and $4.6 billion in Q2 2025.